Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$839K Buy
2,318
+214
+10% +$73.3K 0.26% 108
2026
Q1
$741K Sell
2,104
-152
-7% -$54.2K 0.25% 108
2025
Q4
$739K Buy
2,256
+48
+2% +$15.2K 0.26% 108
2025
Q3
$623K Buy
2,208
+17
+0.8% +$4.93K 0.23% 122
2025
Q2
$612K Sell
2,191
-98
-4% -$27.8K 0.24% 116
2025
Q1
$713K Buy
2,289
+176
+8% +$52K 0.31% 109
2024
Q4
$551K Buy
2,113
+152
+8% +$45.1K 0.25% 116
2024
Q3
$632K Sell
1,961
-215
-10% -$70.3K 0.29% 115
2024
Q2
$680K Buy
2,176
+186
+9% +$54.6K 0.35% 101
2024
Q1
$566K Sell
1,990
-157
-7% -$45.9K 0.32% 104
2023
Q4
$619K Sell
2,147
-45
-2% -$12.3K 0.4% 91
2023
Q3
$589K Buy
2,192
+69
+3% +$17.2K 0.44% 81
2023
Q2
$471K Buy
2,123
+69
+3% +$16K 0.37% 88
2023
Q1
$497K Buy
2,054
+285
+16% +$70K 0.44% 76
2022
Q4
$465K Buy
+1,769
New +$474K 0.47% 75

Other funds holding AMGN

HF Advisory Group's AMGN Position: Q2 2026 in Review

HF Advisory Group increased its Amgen (AMGN) stake by 10% in Q2 2026, buying an estimated $73.3K and bringing the position to 2,318 shares worth $839K. The position accounts for 0.26% of the portfolio, ranked #108.

HF Advisory Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,456 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • HF Advisory Group held 2,318 shares of Amgen worth $839K as of Q2 2026.
  • HF Advisory Group bought 214 Amgen shares in Q2 2026, an estimated $73.3K.
  • Amgen made up 0.26% of HF Advisory Group's portfolio in Q2 2026, its #108 holding.
  • HF Advisory Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 1,456 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HF Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.